Download What Factors Contribute to the Risk for MS?

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Molecular mimicry wikipedia , lookup

Phagocyte wikipedia , lookup

T cell wikipedia , lookup

Lymphopoiesis wikipedia , lookup

Immune system wikipedia , lookup

Polyclonal B cell response wikipedia , lookup

Adaptive immune system wikipedia , lookup

Pathophysiology of multiple sclerosis wikipedia , lookup

Cancer immunotherapy wikipedia , lookup

Immunomics wikipedia , lookup

Immunosuppressive drug wikipedia , lookup

Innate immune system wikipedia , lookup

Adoptive cell transfer wikipedia , lookup

Hygiene hypothesis wikipedia , lookup

Sjögren syndrome wikipedia , lookup

Psychoneuroimmunology wikipedia , lookup

Transcript
What Factors Contribute to the
Risk for MS?
MS Epidemiology
Prevalence
~350,000 persons in the United
States
Sex distribution
~75% female
Age at onset
Ethnic origin
Typically 20−40 years,
but can present at any age
Predominantly Caucasian
Compston A, et al. McAlpine’s Multiple Sclerosis, 4th ed. Churchill Livingston; 2006. Hauser
SL, et al. Multiple Sclerosis. In: Fauci AS, et al. Harrison’s Principles of Internal Medicine. Available at:
http://www.accessmedicine.com/content.aspx?aID=2906448. Accessed on: February 19, 2010.
Multiple Sclerosis
An Immunogenetic Disease
Environmental Factors
Genetic Predisposition
Immune Dysregulation
MS
Graphic courtesy of Suhayl Dhib-Jalbut, MD.
Approximate Probability of
Developing MS
Evidence for Genetic Basis of MS
50
45
40
35
30
25
20
15
10
5
0
25%
5%
3%
2%
1%
0.1%
0.1%
Identical Fraternal Sibling Parent or First
Spouse
No
Twin
Twin
HalfCousin
Family
Sibling
Member
Hauser SL, et al. Multiple Sclerosis. In: Fauci AS, et al, eds. Harrison's Principles of Internal Medicine.
Available at: http://www.accessmedicine.com/content.aspx?aID=2906445. Accessed on: February 19,
2010. Willer CJ, et al. Proc Natl Acad Sci U S A. 2003;100:12877-12882.
Evidence for Environmental
Basis of MS
• No evidence of MS prior to 1822 (~ onset of industrial
revolution in Europe)
• Change in the gender ratio over time
• These changes (eg, gender ratio, increasing
incidence) took place over ~ 30 years (1–2
generations)—too fast for a genetics cause
• Increased incidence of MS in many regions
(especially in women)
– When individuals migrate before age 15 from a region of
high MS prevalence to one of low prevalence (or vice versa),
they seem to adopt a prevalence similar to that of the region
to which they moved
– When they make the same move after age 15, they seem to
retain the risk of the region from which they moved
Multiple Sclerosis
What Are the Environmental Factors?
• Many environmental factors have been
proposed
• Two currently popular candidates for
involvement in MS pathogenesis are:
– Epstein-Barr virus (EBV) infection
– Vitamin D deficiency (sunlight exposure)
• These are hypotheses—not proven facts!
– Either, neither, or both may be correct
Evidence for EBV
• Indirect evidence
– Late EBV infection is associated with MS
– Symptomatic mononucleosis is associated with MS
• Direct evidence
– 10 out of 12 studies found a significantly higher rate of EBV
positivity in MS patients than in controls1-12
– When data from these 12 trials are combined
(N = 4155), EBV positivity is found in 99.5% of MS patients
vs 94.2% of controls (P <10-23)
1. Sumaya, 1980. 2. Bray, 1983. 3. Larson, 1984. 4. Sumaya, 1985. 5. Shirodaria, 1987. 6.
Munch, 1998. 7. Myhr, 1998. 8. Wagner, 2000. 9. Ascherio, 2001. 10. Sundström, 2004. 11.
Haahr, 2004. 12. Ponsonby, 2005.
Worldwide Prevalence of MS
Latitude gradient for UVB is strikingly similar =
indirect evidence for vitamin D hypothesis
≥30 per 100,000 population
5–25 per 100,000 population
<5 per 100,000 population
Reprinted from Kurtzke JF. Acta Neurol Scandinav. 1980;62:65-80, with permission from Blackwell Synergy.
Direct Evidence for Vitamin D
• >185,000 women interviewed about their diet: Those in
highest quintile of vitamin D consumption had significantly
less new-onset MS compared with lowest quintile1
• Study of MS patients and controls from Tasmania found
significant negative association between total sun
exposure during childhood (especially in those 6–10 years
old) and adolescence and the subsequent development of
MS2,3
• Evaluation of stored serum samples from 257 MS patients
and 514 matched controls (US Military) showed the risk of
MS was significantly decreased in those with increased
serum vitamin D3 levels4
1. Munger KL, et al. Neurology. 2004;62:60-65. 2. Van der Mei IA, et al. J Neurol. 2007;254:581-590. 3. Van
der Mei IA, et al. BJM. 2003;327:316. 4. Munger KL, et al. JAMA. 2006;296:2832-2838.
Risk Factors for MS
Summary
• MS is caused by a complex interaction of
genetic and environmental factors
– In someone with an affected identical twin, risk of
MS is 25%, suggesting that genetics play a role in
susceptibility but are not the complete story
• Vitamin D insufficiency and EBV infection
have shown possible links to MS
– This research is thought-provoking, but these
factors have not been definitely proven as causes
of MS
Pathophysiology of MS
Pathophysiology of MS
• Acute Inflammation
• Neuronal Degeneration
Relapses
Disability
Immune Dysregulation in MS
T Cells
• T cells normally recognize specific antigens
– CD8+ T cells destroy infected cells
– CD4+ T cells release cytokines that mediate inflammatory
and anti-inflammatory responses
• T cells reactive to myelin are found in MS lesions,
blood, and cerebrospinal fluid
– CD8+ T cells transect axons, induce oligodendrocyte death,
promote vascular permeability1
– There is a cytokine imbalance in MS, favoring secretion of
inflammatory (Th1) cytokines
– T cells that normally regulate immune function have reduced
activity in MS2
1. Dhib-Jalbut S. Neurology. 2007;68:S13-S21. 2. Viglietta V, et al. J Exp Med. 2004;199:971-979.
Cytokine Imbalance in MS
TH1
Normal
TH2
Inflammatory Anti-inflammatory
IFN-g, IL-12, TNF
IL-4, IL-10, TGFß
TH2
MS
Anti-inflammatory
TH1
Inflammatory
IFN-g, IL-12, TNF
Graphic courtesy of Suhayl Dhib-Jalbut, MD.
IL-4, IL-10,TGFß
Immune Dysregulation in MS
B Cells
• In some MS patients, ectopic lymphoid
follicles have been found in the meninges1
• Mechanisms of B cells in MS may include:
– Antimyelin antibody production
– Antigen presentation to autoreactive T cells
– Proinflammatory cytokine production
1. Uccelli A, et al. Trends Immunol. 2005;26:254-259.
Immune Dysregulation in MS
Other Involved Cells
• Natural killer (NK) cells
– May play opposing roles as both regulators and inducers of
disease relative to cytokine environment and cell:cell contact
– NK cell function may be lost during clinical relapse
• Monocytes
– Secrete IL-6 (promotes B cell growth) and IL-2 (aids
differentiation of Th1 cells)
• Macrophages
– Phagocytic activity may contribute to demyelination
• Microglia
– Specialized macrophages in the CNS, also may contribute to
T cell activation
Neurodegeneration
• Loss of axons is the main cause of permanent
disability in MS
• Axonal damage has been shown to occur in acute
inflammatory plaques1 and can lead to brain atrophy
– Occurs in white and gray matter
– May also produce cognitive impairment
• Axonal damage could be the result of
– Cumulative inflammatory damage over time
– A parallel degenerative process related to loss of trophic
support or an independent axonal degeneration2
• Can effective immune therapy early in MS prevent
worsening disability?
1. Trapp BD, et al. N Engl J Med. 1998;338:278-285. 2. Trapp BD. Neuroscientist. 1999;5:48-57.
Conclusions
• Pathogenesis of MS involves complex interactions
between genetic and environmental factors
– Multiple genes are involved
– Vitamin D deficiency and EBV infection are 2 candidates
• MS incidence has increased over the past 30 years
due to a change in environmental exposure
• MS pathogenesis involves multiple immune cell types
(T cells,
B cells, NK cells, others)
• Along with chronic inflammation, MS pathogenesis
involves axonal loss
– Neurodegeneration is the major source of disability in MS